Isolation and characterization of tumor stem-like cells from human meningiomas
- 510 Downloads
Recent advances in research have found that tumor stem-like cells are resistant to surgery, radiotherapy, and chemotherapy. Tumor stem-like cells play critical roles in tumor recurrence, angiogenesis, and invasion in malignant brain tumors. However, the identification of tumor stem-like cells in meningiomas has not been clarified. In this study, we identified the stem-like features of sphere-forming cells in human meningiomas. The results showed that meningioma stem-like cells possess the ability to form spheres in identical stem cell culture condition. These meningioma sphere cells (MgSCs) expressed progenitor cell marker, CD133, but not differentiated cell marker, epithelial membrane antigen (EMA) on immunofluorescence staining. Importantly, the mRNA expression of ABCG, and CD133 was higher in MgSCs than daughter meningioma adherent cells (MgACs). In addition, cells displayed chemotherapeutic resistance to vincristine more in MgSCs than MgACs. This phenomenon was also found in single cell form from dissociated spheres than MgACs. Moreover, MgSCs are more resistant to irradiation treatment than MgACs. Furthermore, MgSCs revealed high tumorigenicity in vivo following orthotopic inoculation into the brains of immunodeficient mice. The corresponding immunohistochemical (IHC) staining found that MgSCs are positive for EMA, vimentin, and CD133, consistent with IHC of primary human meningiomas. These findings have provided better understanding of meningioma cell biology and suggested that meningioma stem-like cells may serve as a novel target in therapeutic resistant meningiomas.
KeywordsCD133 Chemoresistance Meningioma Radioresistance Sphere Tumor stem-like cell
This study was supported by grants TSGH-C99-069, TSGH-C99-072, TSGH-C99-073, TSGH-C99-074, and TSGH-C99-149, from the Tri-Service General Hospital (D.-Y. Hueng), NSC-96-2628-B-016-002-MY3, NSC98-3112-B-016-002 and NSC99-3112-B-016-001 (H.-K. Sytwu), and a grant B971113 from the Teh-Tzer Study Group for Human Medical Research Foundation, and grants DOH99-TD-B-111-003, and DOH99-TD-C-111-008, from Taiwan Department of Health for the Center of Excellence for Clinical Trial and Research in Neuroscience, and the Center of Excellence for Cancer Research.
- 2.Perez-Bacete MJ, Cerda-Nicolas M, Piquer J, Peydro-Olaya A (1989) Differential immunohistochemical characteristics of meningiomas and other neoplasms of the central nervous system. Arch Neurobiol (Madr) 52:265–272Google Scholar
- 5.Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG II (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60 (discussion 60)PubMedCrossRefGoogle Scholar
- 7.Tseng KY, Chung MH, Sytwu HK, Lee HM, Chen KY, Chang C, Lin CK, Yen CH, Chen JH, Lin GJ, Ma HI, Yeh YS, Ju DT, Liu MY, Hueng DY (2010) Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas. J Neurooncol 100:217–223. doi: 10.1007/s11060-010-0164-2 PubMedCrossRefGoogle Scholar
- 11.Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7:1028–1034PubMedCrossRefGoogle Scholar
- 15.Ma HI, Kao CL, Lee YY, Chiou GY, Tai LK, Lu KH, Huang CS, Chen YW, Chiou SH, Cheng IC, Wong TT (2009) Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis. Childs Nerv Syst 26:293–303PubMedCrossRefGoogle Scholar
- 20.Ma HI, Chiou SH, Hueng DY, Tai KL, Huang PI, Kao CL, Chen YW, Sytwu HK (2010) Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. J Neurosurg. doi: 10.3171/2009.11.JNS091396
- 29.Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106:16281–16286PubMedCrossRefGoogle Scholar
- 39.Hu W, Shen F, Chen G, Shen G, Liu W, Zhou J (2009) Possible involvement of brain tumour stem cells in the emergence of a fast-growing malignant meningioma after surgical resection and radiotherapy of high-grade astrocytoma: case report and preliminary laboratory investigation. J Int Med Res 37:240–246PubMedGoogle Scholar
- 46.Fatoo A, Nanaszko MJ, Allen BB, Mok CL, Bukanova EN, Beyene R, Moliterno JA, Boockvar JA (2010) Understanding the role of tumor stem cells in glioblastoma multiforme: a review article. J Neurooncol. doi: 10.1007/s11060-010-0406-3